Physician profile
Daniel A Deighton
NPI 1508814211
$1,831.47
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $168 · 2020: $192 · 2021: $338 · 2022: $598 · 2023: $513 · 2024: $22.66.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $536.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $536.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $341.66 | 2019-2023 | Myrbetriq, Veozah |
| Axonics, INC. | $220.51 | 2020-2023 | Axonics |
| Sumitomo Pharma America, INC. | $209.26 | 2023-2024 | Gemtesa, Orgovyx |
| Urovant Sciences INC | $176.40 | 2021-2022 | |
| Myovant Sciences INC. | $173.75 | 2021-2022 | |
| Abbvie INC. | $159.13 | 2019-2023 | Botox |
| Endo Pharmaceuticals INC. | $116.98 | 2019-2023 | Aveed, Xiaflex, Edex |
| Boston Scientific Corporation | $87.00 | 2019-2022 | |
| Olympus America INC. | $56.35 | 2019-2021 | |
| Halozyme INC | $44.41 | 2023 | |
| Neotract INC. | $44.01 | 2019 | |
| Janssen Biotech, INC. | $42.01 | 2020-2022 | |
| Abc Home Medical Supply, INC. | $28.45 | 2022 | |
| 180 Medical, INC. | $28.04 | 2019 | |
| Antares Pharma, INC. | $21.58 | 2023 | Nocdurna, Xyosted, Tlando |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $20.21 | 2022 | |
| Urogen Pharma, INC. | $18.56 | 2021 | |
| Rochester Medical Corporation | $17.26 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $13.16 | 2022 | |
| Allergan, INC. | $12.74 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Deighton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.